Remove authors shields-health-solutions
article thumbnail

Top Posters at the 2023 PQA Annual Meeting

PQA

Sponsored by Pharmacy Quality Solutions, the session provided an opportunity for authors to showcase their work and for attendees to engage in insightful dialogue about health care quality. The 2023 PQA Annual Meeting poster session featured 24 quality improvement and research projects.

article thumbnail

PharmaShots' Key Highlights of First Quarter 2023

PharmaShots

The authorization incl. The safety profile was consistent with prior reported studies with no new safety signals & the results will be presented at an upcoming medical meeting & discussed with regulatory authorities The company has a comprehensive clinical development program in EC. Keytruda is being studied as monotx.

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top Performing Drug – Dupixent (April Edition)

PharmaShots

The report is concluded with an engaging SWOT analysis and edifying KOL reviews Active Ingredient: Dupilumab Dosage Forms & Strengths: Single-Dose Pre-Filled Syringe with Needle Shield Injection: 300 mg/2 mL, 200 mg/1.14 mL, 100 mg/0.67 mL Single-Dose Pre-filled pen Injection: 300 mg/2 mL, 200 mg/1.14

Dosage 56
article thumbnail

4 principles for the future of pharma marketing

pharmaphorum

As a consequence, things turned sour when the payers progressively became immune to non “real world data” based evidences and started to challenge the reality of the health benefits while cutting spend. And one great solution to this is the tactical implementation of artificial intelligence. About the authors.